全文获取类型
收费全文 | 10808篇 |
免费 | 959篇 |
国内免费 | 408篇 |
专业分类
耳鼻咽喉 | 17篇 |
儿科学 | 1296篇 |
妇产科学 | 179篇 |
基础医学 | 736篇 |
口腔科学 | 141篇 |
临床医学 | 556篇 |
内科学 | 938篇 |
皮肤病学 | 78篇 |
神经病学 | 86篇 |
特种医学 | 143篇 |
外国民族医学 | 1篇 |
外科学 | 376篇 |
综合类 | 1528篇 |
预防医学 | 1564篇 |
眼科学 | 64篇 |
药学 | 1953篇 |
10篇 | |
中国医学 | 2414篇 |
肿瘤学 | 95篇 |
出版年
2024年 | 53篇 |
2023年 | 164篇 |
2022年 | 638篇 |
2021年 | 778篇 |
2020年 | 466篇 |
2019年 | 366篇 |
2018年 | 379篇 |
2017年 | 457篇 |
2016年 | 461篇 |
2015年 | 448篇 |
2014年 | 845篇 |
2013年 | 862篇 |
2012年 | 661篇 |
2011年 | 694篇 |
2010年 | 529篇 |
2009年 | 440篇 |
2008年 | 393篇 |
2007年 | 413篇 |
2006年 | 336篇 |
2005年 | 288篇 |
2004年 | 272篇 |
2003年 | 224篇 |
2002年 | 203篇 |
2001年 | 171篇 |
2000年 | 155篇 |
1999年 | 124篇 |
1998年 | 117篇 |
1997年 | 107篇 |
1996年 | 112篇 |
1995年 | 89篇 |
1994年 | 113篇 |
1993年 | 74篇 |
1992年 | 75篇 |
1991年 | 47篇 |
1990年 | 54篇 |
1989年 | 50篇 |
1988年 | 58篇 |
1987年 | 47篇 |
1986年 | 54篇 |
1985年 | 40篇 |
1984年 | 52篇 |
1983年 | 46篇 |
1982年 | 66篇 |
1981年 | 41篇 |
1980年 | 25篇 |
1979年 | 24篇 |
1978年 | 17篇 |
1977年 | 12篇 |
1976年 | 12篇 |
1975年 | 9篇 |
排序方式: 共有10000条查询结果,搜索用时 62 毫秒
91.
目的:分析地黄在中药类保健食品中生熟异用下的配方规律。方法:收集国家市场监督管理总局(SAMR)特殊食品信息查询平台公布的生、熟地黄保健食品数据,对其保健功能及中药组方等进行统计,运用Apriori算法和Kulc、不平衡比参数对地黄生熟异用的保健食品配方规律进行分析。结果:保健食品中,生地黄主要用于辅助降血糖,熟地黄主要用于增强免疫力、缓解体力疲劳、改善营养性贫血。在辅助降血糖类生地黄保健食品中,生地黄主要与补气药、补阴药、解表药、解热药配伍,代表性组合为生地黄-黄芪-苦瓜;在增强免疫力类熟地黄保健食品中,熟地黄主要与补气药、补血药、补阴药配伍,代表性组合为熟地黄-党参-阿胶;在缓解体力疲劳类熟地黄保健食品中,熟地黄主要与补气药、补阳药、补阴药配伍,代表性组合为熟地黄-人参-淫羊藿、熟地黄-人参-枸杞子;在改善营养性贫血类熟地黄保健食品中,熟地黄主要与补气药、补血药配伍,代表性组合为熟地黄-黄芪-阿胶、熟地黄-黄芪-当归。结论:地黄在保健食品中的使用遵循生熟异用的规律,在不同保健功能中,组方配伍基本符合中医理论和现代医学理论,可为生、熟地黄保健食品研发提供借鉴和依据。 相似文献
92.
阿尔茨海默病(AD)是最常见的痴呆形式,目前缺少疾病修饰性的治疗药物。中医理论认为肾精亏虚是AD发生发展的内在机制,补肾益精是中医治疗AD的基本原则,贯穿AD治疗的始终。补肾益智方是治疗AD的临床经验方。补肾益智方治疗AD已有大量文献报道,但补肾益智方缺乏临床应用安全性评价,同时其基础研究薄弱,有效成分不明、多靶点作用机制不清。为阐明补肾益智方多成分、多靶点、多途径治疗AD的作用机制,该文综述了补肾益智方治疗AD的研究进展。进一步收集了16个基于高效液相色谱指纹图谱的补肾益智方主要化学成分,并对其成药性与安全性进行评价。利用基于AD重要病理生理学过程的网络药理学与文献综述相结合的方法,深入分析了补肾益智方靶向胆碱能系统、AD神经病理学特征的有效成分及可能机制。该研究为AD对症治疗、疾病修饰性治疗的药物研发提供了一系列有潜力的先导化合物,并为深入拓展补肾益智方的临床应用提供了理论依据。 相似文献
93.
目的 探讨慢溃宁方对葡聚糖硫酸钠(DSS)诱导的溃疡性结肠炎(UC)小鼠肠道菌群的调控作用,和对NOD样受体(NLR)P3/胱天蛋白酶(Caspase)-1/Gasdermin D(GSDMD)细胞焦亡通路所介导炎症的影响。方法 SPF级C57BL/6小鼠60只,随机分为空白组、模型组、慢溃宁方组(20 g·kg-1)、美沙拉秦组(0.266 g·kg-1),各组15只。小鼠通过自由饮用3%DSS溶液,7 d构建UC模型。造模开始12 h后,治疗组每天灌胃给药,其余组灌胃等体积生理盐水。记录小鼠每日体质量等情况,并评估计算疾病活动指数(DAI)。第8天麻醉后,脱臼颈椎处死小鼠,收集结肠和粪便,记量结肠长度;观察结肠组织苏木素-伊红(HE)染色后的病理学改变;结肠中肿瘤坏死因子-α(TNF-α)、白细胞介素-1β(IL-1β)、白细胞介素-18(IL-18)水平用酶联免疫吸附测定法(ELISA)检测;基于16S rRNA测序技术检测各组小鼠粪便中肠道菌群的差异;NLRP3/Caspase-1/GSDMD蛋白结肠组织中含量用蛋白免疫印迹法(Western blot)检测。结果 相较于空白组,模型组小鼠的DAI升高(P<0.01),结肠长度显著缩短(P<0.01),结肠黏膜损伤严重,TNFα、IL-1β、IL-18水平均明显升高(P<0.01),且结肠组织中NLRP3/Caspase-1/GSDMD蛋白含量显著升高(P<0.01),肠道菌群结构改变,门水平上的放线菌门、拟杆菌门与变形菌门丰度减少,厚壁菌门丰度增加;属水平上的乳酸杆菌、普雷沃氏菌和鼠杆菌属丰度减少,拟杆菌属、芽孢杆菌、毛螺旋菌属NK4A136丰度增加。慢溃宁方组、美沙拉秦组相较于模型组,第3天后DAI显著降低(P<0.01),结肠长度均显著增加(P<0.01),结肠的炎症浸润及黏膜结构损伤减轻,且结肠TNF-α、IL-1β、IL-18水平均显著下降(P<0.01),NLRP3/Caspase-1/GSDMD蛋白在结肠组织中的含量明显降低(P<0.05,P<0.01),门水平上的变形菌门和拟杆菌门丰度增加,厚壁菌门丰度减少。结论 慢溃宁方可通过抑制细胞经典焦亡通路,缓解UC小鼠结肠炎症反应,减轻结肠损伤,并对肠道菌群紊乱有改善作用。 相似文献
94.
The gut is a pivotal organ in health and disease. The events that take place in the gut during early life contribute to the programming, shaping and tuning of distant organs, having lifelong consequences. In this context, the maternal gut plays a quintessence in programming the mammary gland to face the nutritional, microbiological, immunological, and neuroendocrine requirements of the growing infant. Subsequently, human colostrum and milk provides the infant with an impressive array of nutrients and bioactive components, including microbes, immune cells, and stem cells. Therefore, the axis linking the maternal gut, the breast, and the infant gut seems crucial for a correct infant growth and development. The aim of this article is not to perform a systematic review of the human milk components but to provide an insight of their extremely complex interactions, which render human milk a unique functional food and explain why this biological fluid still truly remains as a scientific enigma. 相似文献
95.
Katy Sorensen Abbie L. Cawood Glenn R. Gibson Lisa H. Cooke Rebecca J. Stratton 《Nutrients》2021,13(3)
Cow’s milk protein allergy (CMPA) is associated with dysbiosis of the infant gut microbiome, with allergic and immune development implications. Studies show benefits of combining synbiotics with hypoallergenic formulae, although evidence has never been systematically examined. This review identified seven publications of four randomised controlled trials comparing an amino acid formula (AAF) with an AAF containing synbiotics (AAF-Syn) in infants with CMPA (mean age 8.6 months; 68% male, mean intervention 27.3 weeks, n = 410). AAF and AAF-Syn were equally effective in managing allergic symptoms and promoting normal growth. Compared to AAF, significantly fewer infants fed AAF-Syn had infections (OR 0.35 (95% CI 0.19–0.67), p = 0.001). Overall medication use, including antibacterials and antifectives, was lower among infants fed AAF-Syn. Significantly fewer infants had hospital admissions with AAF-Syn compared to AAF (8.8% vs. 20.2%, p = 0.036; 56% reduction), leading to potential cost savings per infant of £164.05–£338.77. AAF-Syn was associated with increased bifidobacteria (difference in means 31.75, 95% CI 26.04–37.45, p < 0.0001); reduced Eubacterium rectale and Clostridium coccoides (difference in means −19.06, 95% CI −23.15 to −14.97, p < 0.0001); and reduced microbial diversity (p < 0.05), similar to that described in healthy breastfed infants, and may be associated with the improved clinical outcomes described. This review provides evidence that suggests combining synbiotics with AAF produces clinical benefits with potential economic implications. 相似文献
96.
Gestational diabetes mellitus (GDM) is associated with an increased risk of having a high-care newborn and has an impact on maternal wellbeing. This study aimed to assess the effect of GDM on the lactoferrin (LF), secretory immunoglobulin A (SIgA), immunoglobulin G (IgG), and immunoglobulin M (IgM) concentrations in early colostrum, colostrum, and transitional milk samples of hyperglycemic (n = 53) and normoglycemic (n = 49) mothers using enzyme-linked immunosorbent assay (ELISA). The concentrations of milk lactoferrin and SIgA, but not IgG and IgM, from hyperglycemic and normoglycemic mothers, showed a similar negative correlation with lactation from the first to the fifteenth day. Apart from early colostral IgG, there were no differences in concentrations of LF and immunoglobulins in milk from hyperglycemic and normoglycemic mothers. For hyperglycemia compensated by diet (GDM G1) or insulin treatment (GDM G2), slight differences were seen for LF and IgG, but not for SIgA and IgM, during an early stage of lactation only. Early colostral IgG and colostral LF of insulin-treated mothers were higher (10.01 ± 4.48 mg/L and 11.50 ± 0.58 g/L, respectively) than for diet-control diabetic mothers (7.65 ± 5.67 mg/L and 8.05 ± 1.38 g/L, respectively). GDM of mothers does not have a significant impact on immunological quality of early milk. 相似文献
97.
Franka Neumer Orenci Urraca Joaquin Alonso Jesús Palencia Vicente Varea Stephan Theis Maria Rodriguez-Palmero Jos Antonio Moreno-Muoz Francisco Guarner Gigi Veereman Yvan Vandenplas Cristina Campoy 《Nutrients》2021,13(4)
The present study aims to evaluate the effects of an infant formula supplemented with a mixture of prebiotic short and long chain inulin-type oligosaccharides on health outcomes, safety and tolerance, as well as on fecal microbiota composition during the first year of life. In a prospective, multicenter, randomized, double-blind study, n = 160 healthy term infants under 4 months of age were randomized to receive either an infant formula enriched with 0.8 g/dL of Orafti®Synergy1 or an unsupplemented control formula until the age of 12 months. Growth, fever (>38 °C) and infections were regularly followed up by a pediatrician. Digestive symptoms, stool consistency as well as crying and sleeping patterns were recorded during one week each study month. Fecal microbiota and immunological biomarkers were determined from a subgroup of infants after 2, 6 and 12 months of life. The intention to treat (ITT) population consisted of n = 149 infants. Both formulae were well tolerated. Mean duration of infections was significantly lower in the prebiotic fed infants (p < 0.05). The prebiotic group showed higher Bifidobacterium counts at month 6 (p = 0.006), and higher proportions of Bifidobacterium in relation to total bacteria at month 2 and 6 (p = 0.042 and p = 0.013, respectively). Stools of infants receiving the prebiotic formula were softer (p < 0.05). Orafti®Synergy1 tended to beneficially impact total daily amount of crying (p = 0.0594). Supplementation with inulin-type prebiotic oligosaccharides during the first year of life beneficially modulates the infant gut microbiota towards higher Bifidobacterium levels at the first 6 months of life, and is associated with reduced duration of infections. 相似文献
98.
Kruti B. Shah Steven D. Chernausek Lori D. Garman Nathan P. Pezant Jasmine F. Plows Harmeet K. Kharoud Ellen W. Demerath David A. Fields 《Nutrients》2021,13(4)
Among all the body fluids, breast milk is one of the richest sources of microRNAs (miRNAs). MiRNAs packaged within the milk exosomes are bioavailable to breastfeeding infants. The role of miRNAs in determining infant growth and the impact of maternal overweight/obesity on human milk (HM) miRNAs is poorly understood. The objectives of this study were to examine the impact of maternal overweight/obesity on select miRNAs (miR-148a, miR-30b, miR-29a, miR-29b, miR-let-7a and miR-32) involved in adipogenesis and glucose metabolism and to examine the relationship of these miRNAs with measures of infant body composition in the first 6 months of life. Milk samples were collected from a cohort of 60 mothers (30 normal-weight [NW] and 30 overweight [OW]/obese [OB]) at 1-month and a subset of 48 of these at 3 months of lactation. Relative abundance of miRNA was determined using real-time PCR. The associations between the miRNAs of interest and infant weight and body composition at one, three, and six months were examined after adjusting for infant gestational age, birth weight, and sex. The abundance of miR-148a and miR-30b was lower by 30% and 42%, respectively, in the OW/OB group than in the NW group at 1 month. miR-148a was negatively associated with infant weight, fat mass, and fat free mass, while miR-30b was positively associated with infant weight, percent body fat, and fat mass at 1 month. Maternal obesity is negatively associated with the content of select miRNAs in human milk. An association of specific miRNAs with infant body composition was observed during the first month of life, suggesting a potential role in the infant’s adaptation to enteral nutrition. 相似文献
99.
Alicja Ewa Ratajczak Agnieszka Zawada Anna Maria Rychter Agnieszka Dobrowolska Iwona Krela-Ka
mierczak 《Nutrients》2021,13(4)
Osteoporosis affects women twice as often as men. Additionally, it is estimated that 0.3 million and 1.7 million people have hip fractures in the USA and Europe, respectively. Having a proper peak bone mass and keeping it as long as possible is especially important for osteoporosis prevention. One of the most important calcium sources is milk and dairy products. Breast milk is the best infant food, but milk should not be avoided later in life to prevent losing bone mass. On the other hand, more and more people limit their milk consumption and consume other dairy or non-dairy products. For example, they are usually replaced with plant beverages, which should be consumed carefully in several age groups. Additionally, an important element of milk and dairy products, as well as plant beverages, are probiotics and prebiotics, which may modulate bone turnover. Dietary recommendations focused on milk, and dairy products are an important element for the prevention of osteoporosis. 相似文献
100.
Jian Zhang Ai Zhao Shiyun Lai Qingbin Yuan Xiaojiang Jia Peiyu Wang Yumei Zhang 《Nutrients》2021,13(5)
Our knowledge related to human milk proteins is still limited. The present study determined the changes in multiple human milk proteins during the first six months of lactation, investigated the influencing factors of milk proteins, and explored the impact of milk proteins on infant growth. A total of 105 lactating women and their full-term infants from China were prospectively surveyed in this research. Milk samples were collected at 1–5 days, 8–14 days, 1 month, and 6 months postpartum. Concentrations of total protein and α-lactalbumin were measured in all milk samples, and concentrations of lactoferrin, osteopontin, total casein, β-casein, αs−1 casein, and κ-casein were measured in milk from 51 individuals using ultra performance liquid chromatography coupled with mass spectrometry. The concentration of measured proteins in the milk decreased during the first six months of postpartum (p-trend < 0.001). Maternal age, mode of delivery, maternal education, and income impacted the longitudinal changes in milk proteins (p-interaction < 0.05). Concentrations of αs−1 casein in milk were inversely associated with the weight-for-age Z-scores of the infants (1 m: r −0.29, p 0.038; 6 m: r −0.33, p 0.020). In conclusion, the concentration of proteins in milk decreased over the first six months postpartum, potentially influenced by maternal demographic and delivery factors. Milk protein composition may influence infant weights. 相似文献